ES2076229T3 - Producto de utilidad en un ensayo epicutaneo oclusivo para poder demostrar la alergia por contacto a formaldehido. - Google Patents

Producto de utilidad en un ensayo epicutaneo oclusivo para poder demostrar la alergia por contacto a formaldehido.

Info

Publication number
ES2076229T3
ES2076229T3 ES89850192T ES89850192T ES2076229T3 ES 2076229 T3 ES2076229 T3 ES 2076229T3 ES 89850192 T ES89850192 T ES 89850192T ES 89850192 T ES89850192 T ES 89850192T ES 2076229 T3 ES2076229 T3 ES 2076229T3
Authority
ES
Spain
Prior art keywords
formaldehyde
allergy
oclusive
demonstrate
contact
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89850192T
Other languages
English (en)
Inventor
Kurt Hedegaard
Sten Albrechtsen
Jens Hansen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia AB filed Critical Pharmacia AB
Application granted granted Critical
Publication of ES2076229T3 publication Critical patent/ES2076229T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/0035—Vaccination diagnosis other than by injuring the skin, e.g. allergy test patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0006—Skin tests, e.g. intradermal testing, test strips, delayed hypersensitivity
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)

Abstract

TIRA DE ENSAYO QUE TIENE POR LO MENOS UN PARCHE Y PROPUESTA PARA USAR EN ENSAYO EPICUTANEO OCLUSIVO, A FIN DE DETECTAR ALERGIA AL FORMALDEHIDO POR CONTACTO. EL HECHO CARACTERISTICO ES QUE, POR LO MENOS EN UNO DE DICHOS PARCHES, LA SUSTANCIA DE ENSAYO ES UN DERIVADO N-FORMALDEHIDO REVERSIBLE DE UNA CARBOXAMIDA O -IMIDA, FORMULANDOSE DICHA SUSTANCIA DE ENSAYO EN UN VEHICULO SECO.
ES89850192T 1988-06-28 1989-06-09 Producto de utilidad en un ensayo epicutaneo oclusivo para poder demostrar la alergia por contacto a formaldehido. Expired - Lifetime ES2076229T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8802403A SE8802403D0 (sv) 1988-06-28 1988-06-28 Alster att anvendas vid ocklusiv epikutantestning for att pavisa kontaktallergi mot formaldehyd

Publications (1)

Publication Number Publication Date
ES2076229T3 true ES2076229T3 (es) 1995-11-01

Family

ID=20372747

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89850192T Expired - Lifetime ES2076229T3 (es) 1988-06-28 1989-06-09 Producto de utilidad en un ensayo epicutaneo oclusivo para poder demostrar la alergia por contacto a formaldehido.

Country Status (8)

Country Link
US (1) US5182081A (es)
EP (1) EP0352242B1 (es)
JP (1) JP2972252B2 (es)
AT (1) ATE126891T1 (es)
DE (1) DE68923917T2 (es)
ES (1) ES2076229T3 (es)
SE (1) SE8802403D0 (es)
WO (1) WO1990000064A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985356A (en) 1994-10-18 1999-11-16 The Regents Of The University Of California Combinatorial synthesis of novel materials
US6063633A (en) 1996-02-28 2000-05-16 The University Of Houston Catalyst testing process and apparatus
FR2924349B1 (fr) 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
US20170007170A1 (en) 2015-07-10 2017-01-12 Rememdia LC Allergy Skin Test Devices
CA3020932A1 (en) 2017-10-17 2019-04-17 John Elliott Multiple well epicutaneous test patch array

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2304817A (en) * 1941-07-19 1942-12-15 Grozin Maurice Patch test
US4450844A (en) * 1981-11-23 1984-05-29 Hill Top Research, Inc. Patch system for use on the skin
SE443914B (sv) * 1984-10-01 1986-03-17 Torkel Ingemar Fischer Medel for en overkenslighetstest
DE3527893A1 (de) * 1985-08-03 1987-02-05 Merck Patent Gmbh Epikutan-testpflaster
SE452251B (sv) * 1986-06-26 1987-11-23 Pharmacia Ab Testremsa avsedd att anvendas vid ocklusiv epikutantest for att pavisa kontaktallergi

Also Published As

Publication number Publication date
SE8802403D0 (sv) 1988-06-28
EP0352242B1 (en) 1995-08-23
DE68923917D1 (de) 1995-09-28
EP0352242A3 (en) 1991-01-16
JP2972252B2 (ja) 1999-11-08
JPH03500175A (ja) 1991-01-17
DE68923917T2 (de) 1996-03-14
EP0352242A2 (en) 1990-01-24
WO1990000064A1 (en) 1990-01-11
US5182081A (en) 1993-01-26
ATE126891T1 (de) 1995-09-15

Similar Documents

Publication Publication Date Title
AR220388A1 (es) Tira de ensayo para la evaluacion de sustancias disueltas en soluciones acuosas y procedimiento
KR870700323A (ko) 과민성 시험 방법
BR7804265A (pt) Processo para polimerizar alfa-olefinas,e componentes de catalisador utilizaveis no mesmo
ATA880077A (de) Vorrichtung zum einregeln eines ueber die breite einer laufenden textilbahn gleichmaessigen, vorgegebenen feuchtigkeitsgehaltes bei der einer hautpttrocknung vorgeschalteten vortrocknung im anschluss an eine kontinuierliche nassbehandlung
FR2472141B1 (fr) Poele destine notamment au camping, au caravaning et au nautisme
DE69115154D1 (de) Konservierung von Zellen als Kontrolle oder Normalmass in zellularer Analyse.
BR7703368A (pt) Derivados de acido 2-4 fenoxi-fenoxi propionico,processo para a sua obtencao e composicoes herbicidas a base dos mesmos
ES2076229T3 (es) Producto de utilidad en un ensayo epicutaneo oclusivo para poder demostrar la alergia por contacto a formaldehido.
DE50112918D1 (de) System zur schmierung und überwachung eines schmierfähigen elements
ES553354A0 (es) Procedimiento para detectar y determinar la concentracion de un analito presente en solucion acuosa
NO165648C (no) Anordning for forankring i mark.
MX164404B (es) Dispositivo y metodo para el analisis de prueba termico de llantas
SE8602841D0 (sv) Testremsa och sett for epikutantestning
DE3775062D1 (de) Empfaengnisverhuetende intrauterinvorrichtung.
ES496680A0 (es) Aparato de frio por sorcion y procedimiento para su funcionamiento.
DK0415458T3 (da) Anvendelse af retinoider til forhindring eller størrelsesreduktion af striae distensae læsioner
ATE185195T1 (de) Vorrichtung zur durchführung eines schwangerschaftstests
DE3771565D1 (de) Rechner fuer die diskrete fourier-transformation mit on-line-testgeraet.
MX21657A (es) Nuevos agonistas de la dopamina y procedimiento para su preparacion
Desrousseaux Measuring Method and Device for the Lengthwise Camber of a Metal Plate
Sharma et al. An index to measure depreciation in air quality in some areas of the Raniganj Coalfield, India.
ES2106688A1 (es) Nuevo soporte laminar aplicable para la realizacion de tests epicutaneos.
SE8703755D0 (sv) Fastsettningsanordning
KR910009130U (ko) 탈수기와 절단기가 부착된 직물용 스프레이더(Spreader)장치
PT879414E (pt) Processo para a avaliacao da migracao dos queratinocitos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 352242

Country of ref document: ES